Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adaptive and Behavioral Changes in Kynurenine 3-Monooxygenase Knockout Mice: Relevance to Psychotic Disorders
Sophie Erhardt, Ana Pocivavsek, Mariaelena Repici, et al.
Biological Psychiatry (2016) Vol. 82, Iss. 10, pp. 756-765
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

Transplantation of microbiota from drug-free patients with schizophrenia causes schizophrenia-like abnormal behaviors and dysregulated kynurenine metabolism in mice
Feng Zhu, Ruijin Guo, Wei Wang, et al.
Molecular Psychiatry (2019) Vol. 25, Iss. 11, pp. 2905-2918
Closed Access | Times Cited: 273
Cross Talk: The Microbiota and Neurodevelopmental Disorders
John R. Kelly, Chiara Minuto, John F. Cryan, et al.
Frontiers in Neuroscience (2017) Vol. 11
Open Access | Times Cited: 248
Mitochondrial Impairment: A Common Motif in Neuropsychiatric Presentation? The Link to the Tryptophan–Kynurenine Metabolic System
Masaru Tanaka, Ágnes Szabó, Eleonóra Spekker, et al.
Cells (2022) Vol. 11, Iss. 16, pp. 2607-2607
Open Access | Times Cited: 133
Modulation of T cells by tryptophan metabolites in the kynurenine pathway
Trevor W. Stone, Richard Williams
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 7, pp. 442-456
Open Access | Times Cited: 79
The role of the gut microbiome in the development of schizophrenia
John R. Kelly, Chiara Minuto, John F. Cryan, et al.
Schizophrenia Research (2020) Vol. 234, pp. 4-23
Open Access | Times Cited: 92
Mitochondrial Impairment: A Common Motif in Neuropsychiatric Presentation? The Link to the Tryptophan-Kynurenine Metabolic System
Masaru Tanaka, Ágnes Szabó, Eleonóra Spekker, et al.
(2022)
Open Access | Times Cited: 50
Activated Tryptophan-Kynurenine metabolic system in the human brain is associated with learned fear
Maria Rita Battaglia, Chiara Di Fazio, Simone Battaglia
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 42
Neuroactive Kynurenines as Pharmacological Targets: New Experimental Tools and Exciting Therapeutic Opportunities
Ana Pocivavsek, Robert Schwarcz, Sophie Erhardt
Pharmacological Reviews (2024) Vol. 76, Iss. 6, pp. 978-1008
Closed Access | Times Cited: 9
Constitutive loss of kynurenine-3-monooxygenase changes circulating kynurenine metabolites without affecting systemic energy metabolism
Kyle Dumont, Paulo R. Jannig, Margareta Porsmyr‐Palmertz, et al.
AJP Endocrinology and Metabolism (2025) Vol. 328, Iss. 2, pp. E274-E285
Closed Access | Times Cited: 1
Exhaustion of CD4+ T-cells mediated by the Kynurenine Pathway in Melanoma
Soudabeh Rad Pour, Hiromasa Morikawa, Narsis A. Kiani, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 67
Pro-Inflammatory Cytokines: Potential Links between the Endocannabinoid System and the Kynurenine Pathway in Depression
Ferenc Zádor, Sâmia R.L. Joca, Gábor Nagy-Grócz, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5903-5903
Open Access | Times Cited: 45
The stress of losing sleep: Sex-specific neurobiological outcomes
Courtney J. Wright, Snezana Milosavljevic, Ana Pocivavsek
Neurobiology of Stress (2023) Vol. 24, pp. 100543-100543
Open Access | Times Cited: 21
Maternal Inflammation with Elevated Kynurenine Metabolites Is Related to the Risk of Abnormal Brain Development and Behavioral Changes in Autism Spectrum Disorder
Yuki Murakami, Yukio Imamura, Yoshiyuki Kasahara, et al.
Cells (2023) Vol. 12, Iss. 7, pp. 1087-1087
Open Access | Times Cited: 17
Addiction and the kynurenine pathway: A new dancing couple?
Nuria Morales‐Puerto, Pablo Giménez‐Gómez, Mercedes Pérez‐Hernández, et al.
Pharmacology & Therapeutics (2021) Vol. 223, pp. 107807-107807
Closed Access | Times Cited: 38
The kynurenine pathway in treatment-resistant schizophrenia at the crossroads between pathophysiology and pharmacotherapy
Jacopo Sapienza, Giulia Agostoni, Stefano Dall’Acqua, et al.
Schizophrenia Research (2023) Vol. 264, pp. 71-80
Closed Access | Times Cited: 14
Microglial Ffar4 deficiency promotes cognitive impairment in the context of metabolic syndrome
Wei Wang, Jinyou Li, Siyuan Cui, et al.
Science Advances (2024) Vol. 10, Iss. 5
Open Access | Times Cited: 6
The inhibition of the kynurenine pathway prevents behavioral disturbances and oxidative stress in the brain of adult rats subjected to an animal model of schizophrenia
Gislaine Z. Réus, Indianara R. T. Becker, Giselli Scaini, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2017) Vol. 81, pp. 55-63
Closed Access | Times Cited: 46
Acute Kynurenine Challenge Disrupts Sleep–Wake Architecture and Impairs Contextual Memory in Adult Rats
Ana Pocivavsek, Annalisa M. Baratta, Jessica A. Mong, et al.
SLEEP (2017) Vol. 40, Iss. 11
Open Access | Times Cited: 40
Behavioral Tasks Evaluating Schizophrenia-like Symptoms in Animal Models: A Recent Update
Mary Jasmin Ang, Sueun Lee, Jong-Choon Kim, et al.
Current Neuropharmacology (2020) Vol. 19, Iss. 5, pp. 641-664
Open Access | Times Cited: 33
Kynurenine pathway metabolites modulated the comorbidity of IBD and depressive symptoms through the immune response
Weiming Lai, Ziheng Huang, Sheng Li, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109840-109840
Closed Access | Times Cited: 11
The Complex World of Kynurenic Acid: Reflections on Biological Issues and Therapeutic Strategy
Trevor W. Stone, L. Gail Darlington, Abdulla A.‐B. Badawy, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 9040-9040
Open Access | Times Cited: 4
Altered kynurenine pathway metabolites in a mouse model of human attention-deficit hyperactivity/autism spectrum disorders: A potential new biological diagnostic marker
Yuki Murakami, Yukio Imamura, Kuniaki Saito, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 35
Galantamine-Memantine Combination and Kynurenine Pathway Enzyme Inhibitors in the Treatment of Neuropsychiatric Disorders
Michael Y. Bai, David B. Lovejoy, Gilles J. Guillemin, et al.
Complex Psychiatry (2021) Vol. 7, Iss. 1-2, pp. 19-33
Open Access | Times Cited: 26
A Role for Xanthurenic Acid in the Control of Brain Dopaminergic Activity
Omar Taleb, Mohammed Maammar, Christian Klein, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6974-6974
Open Access | Times Cited: 24
Kynurenine‐3‐monooxygenase (KMO): From its biological functions to therapeutic effect in diseases progression
Yanmei Chen, Jiahui Zhang, Yueying Yang, et al.
Journal of Cellular Physiology (2022) Vol. 237, Iss. 12, pp. 4339-4355
Closed Access | Times Cited: 18
Page 1 - Next Page

Scroll to top